Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to produce and release growth hormone. Body weight changes during sermorelin treatment are a topic of interest. While not a primary effect, understanding its potential influence on mass is crucial.
The primary therapeutic goal of sermorelin is to increase growth hormone levels, which can lead to various beneficial effects, including improved muscle mass, reduced body fat, and increased energy. Historically, growth hormone therapy has been associated with these metabolic changes, and because sermorelin influences growth hormone production, its effect on body composition is relevant. However, the specific impact on weight can be multifaceted and depends on individual factors.
